Emerald Advisers’s Pediatrix Medical MD Stock Holding History

Emerald Advisers’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-586	Closed	-$10K	–	348
2020 Q2	$10K	Buy	+586	New	+$8.69K	﹤0.01%	301

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Emerald Advisers's MD Position: Q3 2020 in Review

Emerald Advisers sold out of Pediatrix Medical (MD) in Q3 2020, closing a stake of 586 shares — an estimated $10K sold.

Emerald Advisers first reported a position in MD in Q2 2020 and held it in 1 quarter. The position peaked at $10K in Q2 2020. 207 funds tracked by Wall St. Rank hold MD as of Q3 2020.

Emerald Advisers reported no remaining Pediatrix Medical position as of Q3 2020 after selling out during the quarter.
Emerald Advisers sold 586 Pediatrix Medical shares in Q3 2020, an estimated $10K.
Emerald Advisers first reported a position in Pediatrix Medical in Q2 2020 and held it in 1 quarter.
Emerald Advisers's Pediatrix Medical position peaked at $10K in Q2 2020.
207 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2020.

Based on Emerald Advisers's 13F filing for Q3 2020, filed 28 Oct 2020.